RUBY Chart
- 52-Week Range: $1.01 - $28.43
- Market Capitalization: $83.71M
- Short Percentage: 0%
- Target Price: $7.00
- Shares Outstanding: 90.21M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RUBY released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Rubius Therapeutics Appoints Noubar Afeyan as Chairman of its Board of DirectorsGlobeNewsWire | May 24th
- Rubius Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire | February 25th
- Rubius Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | February 14th
- Rubius Therapeutics to Present at the Virtual 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 4th
Company Info
Website: https://www.rubiustx.com
Address: 399 Binney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 269
Address: 399 Binney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 269
$RUBY Free money indeed??
$RUBY Let it go...
$RUBY Bull trap
$RUBY has just been halted from trading due to volatility.
$RUBY has just been halted from trading due to volatility.
$RUBY cup and handle dont play
$RUBY omg lol
$RUBY so tired of this pos let's fly already
$RUBY Of course
$RUBY starting to gap up a little